NASDAQ: FENC
Fennec Pharmaceuticals Inc Stock

$5.65+0.21 (+3.86%)
Updated Apr 23, 2025
FENC Price
$5.65
Fair Value Price
N/A
Market Cap
$155.91M
52 Week Low
$3.96
52 Week High
$10.07
P/E
-282.5x
P/B
-26.55x
P/S
3.63x
PEG
N/A
Dividend Yield
N/A
Revenue
$47.54M
Earnings
-$436.00k
Gross Margin
93.3%
Operating Margin
8.41%
Profit Margin
-0.9%
Debt to Equity
-8.65
Operating Cash Flow
$27M
Beta
0.67
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

FENC Overview

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine FENC's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
FENC
Ranked
#32 of 461

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important FENC news, forecast changes, insider trades & much more!

FENC News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FENC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FENC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FENC is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
FENC's Earnings (EBIT) of $4.00M... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more FENC due diligence checks available for Premium users.

Valuation

FENC fair value

Fair Value of FENC stock based on Discounted Cash Flow (DCF)

Price
$5.65
Fair Value
-$3.34
Undervalued by
269.30%
FENC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

FENC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-282.5x
Industry
-284.95x
Market
26.95x

FENC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-26.55x
Industry
4.25x

FENC's financial health

Profit margin

Revenue
$7.9M
Net Income
-$2.0M
Profit Margin
-25%
FENC's Earnings (EBIT) of $4.00M... subscribe to Premium to read more.
Interest Coverage Financials
FENC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$44.9M
Liabilities
$50.8M
Debt to equity
-8.65
FENC's short-term assets ($44.12M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FENC's short-term assets ($44.12M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FENC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FENC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.5M
Investing
$0.0
Financing
-$12.2M
FENC's operating cash flow ($26.98M)... subscribe to Premium to read more.
Debt Coverage Financials

FENC vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
FENCC$155.91M+3.86%-282.50x-26.55x
NBTX$156.22M+1.89%-2.06x-2.14x
SLND$156.63M+8.85%-3.35x-1.17x
NKTXD$154.69M-1.80%-1.36x0.38x
TARAC$154.42M+6.60%-1.94x0.92x

Fennec Pharmaceuticals Stock FAQ

What is Fennec Pharmaceuticals's quote symbol?

(NASDAQ: FENC) Fennec Pharmaceuticals trades on the NASDAQ under the ticker symbol FENC. Fennec Pharmaceuticals stock quotes can also be displayed as NASDAQ: FENC.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.

What is the 52 week high and low for Fennec Pharmaceuticals (NASDAQ: FENC)?

(NASDAQ: FENC) Fennec Pharmaceuticals's 52-week high was $10.07, and its 52-week low was $3.96. It is currently -43.87% from its 52-week high and 42.68% from its 52-week low.

How much is Fennec Pharmaceuticals stock worth today?

(NASDAQ: FENC) Fennec Pharmaceuticals currently has 27,594,008 outstanding shares. With Fennec Pharmaceuticals stock trading at $5.65 per share, the total value of Fennec Pharmaceuticals stock (market capitalization) is $155.91M.

Fennec Pharmaceuticals stock was originally listed at a price of $113.40 in Nov 12, 2004. If you had invested in Fennec Pharmaceuticals stock at $113.40, your return over the last 20 years would have been -95.02%, for an annualized return of -13.93% (not including any dividends or dividend reinvestments).

How much is Fennec Pharmaceuticals's stock price per share?

(NASDAQ: FENC) Fennec Pharmaceuticals stock price per share is $5.65 today (as of Apr 23, 2025).

What is Fennec Pharmaceuticals's Market Cap?

(NASDAQ: FENC) Fennec Pharmaceuticals's market cap is $155.91M, as of Apr 24, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Fennec Pharmaceuticals's market cap is calculated by multiplying FENC's current stock price of $5.65 by FENC's total outstanding shares of 27,594,008.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.